Vitamin K2 Market by Product Type (MK-4, MK-7), Source (Natural, Synthetic), Form (Capsules & Tablets, Powder & Crystalline, Oils & Liquid), Application (Pharmaceutical, Functional Food & Beverages, Health Supplements), Function - Global Forecast to 2029
[200 Pages Report] The global vitamin K2 market is on a trajectory of significant expansion, with an estimated value projected to reach USD 265 million by 2029 from the 2024 valuation of USD 140 million, displaying a promising Compound Annual Growth Rate (CAGR) of 13.7%. As scientific research continues to highlight the benefits of Vitamin K2, particularly in calcium metabolism and the prevention of arterial calcification, more individuals are incorporating this nutrient into their diets. This heightened awareness is especially prevalent among aging populations, who are at greater risk for osteoporosis and cardiovascular diseases, thereby fueling demand for Vitamin K2 supplements.
Another significant contributor to market expansion is the rise of the health and wellness trend. Consumers worldwide are becoming more proactive about their health, seeking preventive measures to avoid chronic diseases. This shift is evident in the growing popularity of dietary supplements and functional foods fortified with essential nutrients like Vitamin K2. Moreover, advancements in the production and formulation of Vitamin K2 supplements are also playing a crucial role in the market’s upward trajectory. Innovations such as microencapsulation and improved delivery systems have enhanced the bioavailability and efficacy of Vitamin K2, making supplements more effective and appealing to consumers. These advancements not only improve the absorption of Vitamin K2 in the body but also extend the shelf life of products, ensuring that consumers receive the maximum benefits from their supplements.
To know about the assumptions considered for the study, Request for Free Sample Report
To know about the assumptions considered for the study, download the pdf brochure
Market Dynamics
Drivers: Growth in health consciousness among consumers and increasing health expenditure
The Vitamin K2 market is experiencing robust growth, primarily driven by the increasing health consciousness among consumers and the rise in health expenditure globally. As more individuals become aware of the importance of preventive healthcare, they are seeking out dietary supplements that can support their long-term well-being. This trend is evident across various demographics, from young adults focused on maintaining their health to older populations looking to manage age-related health issues. The growing emphasis on holistic health and wellness is leading consumers to invest in products that offer specific health benefits, such as improved bone density and cardiovascular health, which are directly linked to Vitamin K2. Additionally, higher disposable incomes and greater health expenditure are enabling consumers to spend more on premium health products, further boosting the demand for Vitamin K2 supplements.
Restraints: Inconsistency in regulatory norms governing vitamin K2
Despite the promising growth prospects, the Vitamin K2 market faces significant challenges due to the inconsistency in regulatory norms across different regions. These regulatory disparities can create barriers for manufacturers and marketers, complicating the process of bringing new Vitamin K2 products to market. Different countries have varying guidelines and standards for the production, labeling, and marketing of dietary supplements, including Vitamin K2. This lack of uniformity can lead to increased costs for compliance and potential delays in product launches. Moreover, stringent regulations in certain regions can limit market entry for new players, hindering the overall growth of the Vitamin K2 market. Navigating these regulatory complexities requires substantial investment in legal and regulatory expertise, which can be a restraint for smaller companies.
Opportunities: Growing demand for natural and functional foods
The growing demand for natural and functional foods presents a significant opportunity for the Vitamin K2 market. Consumers are increasingly seeking out food products that not only provide essential nutrients but also offer additional health benefits. This trend towards functional foods is driven by a desire for more natural and holistic approaches to health and nutrition. Vitamin K2, known for its role in supporting bone and cardiovascular health, is a valuable ingredient in this market. Manufacturers are capitalizing on this opportunity by incorporating Vitamin K2 into a variety of food products, including dairy products, fermented foods, and nutritional bars. The preference for natural ingredients further enhances the appeal of Vitamin K2, as it can be sourced from natural origins such as fermented soybeans (natto) and certain cheeses. This growing demand for functional and natural foods is set to drive the expansion of the Vitamin K2 market.
Challenges: Lack of consumer awareness regarding benefits specific to vitamin K2
One of the key challenges facing the Vitamin K2 market is the lack of consumer awareness regarding its specific benefits. While there is a general understanding of the importance of vitamins for health, the unique benefits of Vitamin K2, such as its role in calcium metabolism and preventing arterial calcification, are not widely known. This lack of awareness can limit consumer demand and slow market growth. Many consumers may not differentiate between Vitamin K1 and Vitamin K2, leading to confusion and underutilization of Vitamin K2 supplements. Addressing this challenge requires concerted efforts in education and marketing to inform consumers about the specific advantages of Vitamin K2. Effective communication strategies, including clear labeling, informative campaigns, and endorsements by health professionals, are essential to bridge this knowledge gap and drive greater adoption of Vitamin K2 products.
Market Ecosystem
Mk-7 Product Type is Witnessing Higher Growth During the Forecast Period.
Menaquinone-7 or MK-7 is the most studied menaquinone due to its high bioavailability, longer half-life, and more than three decades of clinical research. Furthermore, Vitamin K2 MK-7, specifically MenaQ7 and vitaMK7, represents a pivotal advancement in nutritional science, renowned for its dual benefits in bone and cardiovascular health. Distinct from its K1 counterpart, K2 MK-7's superior bioavailability and extended half-life in the body make it optimal for promoting calcium utilization towards bone strength while preventing arterial calcification.
As consumer awareness grows and dietary deficiencies persist, the market potential for K2 MK-7 continues to expand, driven by increasing demand for scientifically validated supplements that address fundamental health challenges across diverse demographic segments.
Pharmaceuticals Emerge As the Second Dominant Application Segment in the Vitamin K2 Market.
The pharmaceutical sector is driven by its extensive therapeutic benefits and increasing incorporation into medical treatments. Vitamin K2’s importance in the pharmaceutical sector is underscored by its application in the prevention and treatment of osteoporosis, cardiovascular diseases, and certain types of cancer. As research continues to unveil the extensive health benefits of vitamin K2, its integration into pharmaceutical products is becoming increasingly prevalent.
Moreover, the potential anticancer properties of vitamin K2 are garnering attention within the pharmaceutical industry. Studies have suggested that vitamin K2 can induce apoptosis in cancer cells and inhibit their proliferation. According to an NCBI study, vitamin K2 induces differentiation and apoptosis in a wide array of human cancer cell lines. However, it is noteworthy that vitamin K2-mediated apoptosis proceeds much more slowly than the apoptosis induced by conventional anticancer agents. The inclusion of vitamin K2 in pharmaceutical products could, therefore, open new avenues for therapeutic interventions, providing patients with innovative treatment options.
Asia Pacific Is The Fastest-Growing Market For Vitamin K2 Among The Regions.
The Asia Pacific region is emerging as the fastest-growing market for Vitamin K2, driven by a combination of demographic, economic, and lifestyle factors. One of the primary drivers of this growth is the region’s rapidly aging population. Countries such as Japan, China, and South Korea are experiencing significant increases in their elderly populations, who are more prone to bone-related ailments like osteoporosis and cardiovascular issues. This demographic shift is creating a substantial demand for nutritional supplements that support bone health and prevent arterial calcification, making Vitamin K2 a sought-after nutrient.
Additionally, The robust growth of the e-commerce sector in the Asia Pacific (APAC) region has significantly facilitated easy access to a wide range of Vitamin K2 products, contributing to the market's expansion. One of the main advantages is the proliferation of online retail platforms, such as Amazon, Alibaba, and other regional e-commerce giants. These platforms have not only increased the visibility of Vitamin K2 supplements but have also allowed for a broader distribution network, reaching consumers in even the most remote areas.
Consumers now have the convenience of shopping from their homes or workplaces, offering a seamless purchasing experience. This accessibility has become even more appealing due to the variety of choices and competitive pricing available on e-commerce platforms. Additionally, online platforms often provide comprehensive product information, customer reviews, and expert advice, empowering consumers to make informed decisions about their health and wellness purchases.
Key Market Players
The key players in this market include Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-OIL MILLS INC. (Japan), Novozymes A/S (Denmark), BASF SE (Germany), Sungen Bioscience Co.,Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), and GENOFOCUS (Korea)
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
:
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Report Metric |
Details |
Market size estimation |
2024–2029 |
Base year considered |
2023 |
Forecast period considered |
2024–2029 |
Units considered |
Value (USD Million), Volume (Tons) |
Segments Covered |
By Product Type, Form, Source, Application, Function, and Region |
Regions covered |
North America, Europe, Asia Pacific, and RoW |
Companies studied |
|
This research report categorizes the vitamin k2 market, based on product type, form, source, application, function, and region.
Target Audience
- Vitamin k2 Manufacturers
- Food & Beverage Producers
- Pharmaceutical companies
- Food Processing Manufacturers
- Government Agencies (related to food safety and regulations such as FDA, EFSA, and FSSAI)
Vitamin K2 Market:
By Product type
- MK-4
- MK-7
By Form
- Capsules & Tablets
- Powder & Crystalline
- Oils & Liquid
By Source
- Natural
- Synthetic
By Application
- Pharmaceuticals
- Functional Food & Beverages
- Health Supplements
By Function (Qualitative)
- Bone & Cardiovascular Health
- Blood Health & Clotting
- Anti-inflammatory & Immune Support
- Other Functions
By Region
- North America
- Europe
- Asia Pacific
- Rest of the World (RoW)
Recent Developments
- In April 2022, GF Fermentech, a subsidiary of Genofocus, introduced a higher-purity variant of its MediQ7 range of vitamin K2 ingredients, named MediQ7 Pure. Derived from Bacillus subtilis natto sourced from traditional Korean fermented food Cheonggukjang, this product boasts over 96% concentration and 99.9% trans-type Menaquinone 7, aligning with USP standards. The ingredients are vegan, kosher, halal, GMP, ISO 9001, and ISO 22000 certified.
- In January 2021, Menadiona launched its Vitamin K2 MK-7 grade. Menadiona has been a consistent supplier of Vitamin K2 MK-4 (Menatetrenone) for the medical treatment of osteoporosis. With the COVID-19 pandemic highlighting a potential link between Vitamin K2 deficiency and the risk of developing the disease, MENADIONA has expanded its product line to include the new MK-7 grade, suitable for nutraceutical formulations in various forms, such as gel, oil, or capsules.
Frequently Asked Questions (FAQ):
What is the current size of the vitamin K2 market?
The vitamin K2 market is estimated at USD 140 million in 2024 and is projected to reach USD 265 million by 2029, at a CAGR of 13.7% from 2024 to 2029.
Which are the key players in the market, and how intense is the competition?
The key players in the vitamin K2 market include Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-OIL MILLS INC. (Japan), Novozymes A/S (Denmark), BASF SE (Germany), Sungen Bioscience Co.,Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), and GENOFOCUS (Korea).
The vitamin K2 market witnesses increased scope for growth. The market is seeing an increase in the number of joint ventures, acquisitions, and new expansions. Moreover, the companies involved in manufacturing vitamin K2 products are investing a considerable proportion of their revenues in research and development activities.
Which region is projected to account for the largest share of the vitamin K2 market?
The Asia Pacific market is expected to dominate during the forecast period. The expansion of the nutraceutical and functional food industries in the Asia-Pacific region is playing a crucial role in the rapid growth of the Vitamin K2 market. There is a burgeoning demand for functional foods and beverages that offer additional health benefits beyond basic nutrition.
What kind of information is provided in the company profile section?
The company profiles mentioned above offer valuable information such as a comprehensive business overview, including details on the company's various business segments, financial performance, geographical reach, revenue composition, and the breakdown of their business revenue. Additionally, these profiles offer insights into the company's product offerings, significant milestones, and expert analyst perspectives to further explain the company's potential.
What are the factors driving the vitamin K2 market?
The Vitamin K2 market is driven by several key factors, including increasing awareness of its health benefits, especially in bone and cardiovascular health. Growing consumer interest in preventive healthcare, coupled with the rise in disposable incomes, has led to increased spending on dietary supplements. Additionally, advancements in scientific research validating Vitamin K2’s efficacy, along with innovations in supplement formulations that enhance bioavailability, contribute to the market’s growth. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
The study involved in estimating the current size of the vitamin k2 market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Secondary Research
This research study involved the extensive use of secondary sources—directories and databases such as Bloomberg Businessweek and Factiva—to identify and collect information useful for a technical, market-oriented, and commercial study of the vitamin k2 market.
In the secondary research process, various sources such as annual reports, press releases & investor presentations of companies, white papers, food journals, certified publications, articles from recognized authors, directories, and databases, were referred to identify and collect information.
Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, and market classification and segmentation as per the industry trends to the bottom-most level, regional markets, and key developments from both market- and technology-oriented perspectives.
Primary Research
Extensive primary research was conducted after obtaining information regarding the vitamin k2 market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, and the Rest of the World. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, research, and development teams, and related key executives from distributors, and key opinion leaders. Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to vitamin k2 product type, form, source, application, function, and region. Stakeholders from the demand side, such as pharmaceutical and food & beverage manufacturers who use vitamin K2, were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage of vitamin k2 and the outlook of their business, which will affect the overall market.
To know about the assumptions considered for the study, download the pdf brochure
COMPANY NAME |
designation |
Gnosis by Lesaffre (NattoPharma) (Norway) |
Regional Sales Manager |
Kappa Bioscience (Balchem Corp.) (US) |
Marketing Manager |
Sungen Bioscience Co., Ltd (China) |
General Manager |
Vesta Nutra (US) |
Sales Manager |
J-OIL MILLS, INC. (Japan) |
Sales Manager |
Novozymes A/S (Denmark) |
Sales Executive |
Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the total market size. These approaches were also used to estimate the size of various dependent submarkets. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets were identified through extensive secondary research.
- All shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
- All possible parameters that affect the markets covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
- The research included the study of reports, reviews, and newsletters of top market players, along with extensive interviews for opinions from leaders, such as CEOs, directors, and marketing executives.
Global Vitamin K2 Market: Bottom-Up Approach.
To know about the assumptions considered for the study, Request for Free Sample Report
Global Vitamin K2 Market: Top-Down Approach.
Data Triangulation
After arriving at the overall market size from the estimation process explained above, the total market was split into several segments and subsegments. To estimate the overall vitamin k2 market and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.
Market Definition
According to the National Institutes of Health (NIH) Office of Dietary Supplements (ODS), Vitamin K2, also called menaquinone (MK), is one of a group of fat-soluble vitamins that play a role in blood clotting and bone health. MK-4 and MK-7 are two specific subtypes of vitamin K2, also known as menaquinone. Both MK-4 and MK-7 are found naturally in some foods and can be taken as supplements. They both play a role in blood clotting and bone health by activating proteins like osteocalcin and matrix Gla protein (MGP).
Key Stakeholders
- Raw material suppliers
- Traders, distributors, and manufacturers & suppliers of vitamin k2
- Food processors & food manufacturers
- Government and research organizations
- Trade associations and industry bodies
-
Regulatory bodies:
- Food and Drug Administration (FDA)
- European Commission
- European Food Safety Authority (EFSA)
- Food Standards Australia New Zealand (FSANZ)
- European Communities
- Associations, and commercial research & development (R&D) institutions:
- Importers and exporters of vitamins
- Global Alliance for Improved Nutrition (GAIN)
- Food Fortification Initiative (FFI)
- Food and Agriculture Organization (FAO)
- United Nations International Children's Emergency Fund (UNICEF)
- World Health Organization (WHO)
- World Organization for Animal Health (WOAH)
Report Objectives
- To define, segment, and forecast the global vitamin K2 market based on product types, forms, sources, function (qualitative), applications, and regions over a historical period from 2020 to 2023 and a forecast period from 2024 to 2029
- To provide detailed information about the key factors influencing the market's growth (drivers, restraints, opportunities, and challenges).
- To identify attractive opportunities in the market by determining the largest and fastest-growing segments across the regions.
-
To analyze the demand-side factors based on the following:
- Impact of macro and microeconomic factors on the market
- Shifts in demand patterns across different subsegments and regions
- To strategically profile the key players and comprehensively analyze their core competencies.
- To analyze competitive developments, such as partnerships, mergers & acquisitions, new product developments, and expansions & investments in the vitamin K2 market.
Available Customizations:
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
The following customization options are available for the report:
Product Analysis
- Product Matrix, which gives a detailed comparison of the product portfolio of each company.
Geographic Analysis
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
- Further breakdown of the Rest of the European vitamin k2 market into key countries
- Further breakdown of the Rest of Asia Pacific vitamin k2 market into key countries
Company Information
- Detailed analyses and profiling of additional market players (up to five)
Growth opportunities and latent adjacency in Vitamin K2 Market